Home

Düşük yenilik paçavra achim aigner leipzig university germany Katlanmak hayal kırıklığı radikal

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig -  ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl

SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection  System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren  istasyonu ilgisiz yerine getirmek
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma

Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 |  Conferenceseries
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Analysis of cellular and molecular antitumor effects upon inhibition of  SATB1 in glioblastoma cells
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells

MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma  Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma  Industry and MedTech | | Pharma Industry and MedTech Congress
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer  Cells In Vitro and In Vivo
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Let Life Sciences meet you Let Life Sciences meet you
Let Life Sciences meet you Let Life Sciences meet you

Perspectives, issues and solutions in RNAi therapy: the expected and the  less expected
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI)  Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn

PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas -  Academia.edu
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

European Technology Platform on Nanomedicine
European Technology Platform on Nanomedicine